Cargando…

Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus

OBJECTIVES: The primary objective of the study was to assess the mean change in hemoglobin A1c (HbA1c) when acarbose was added to insulin and non-insulin regimens in patients with type 2 diabetes mellitus (T2DM). Secondary objectives were to evaluate the discontinuation rate of acarbose, and to asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wettergreen, Sara A., Sheth, Shaila, Malveaux, Janeca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184377/ https://www.ncbi.nlm.nih.gov/pubmed/28042355 http://dx.doi.org/10.18549/PharmPract.2016.04.832

Ejemplares similares

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus
por: Wu, Honghua, et al.
Publicado: (2017)

Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: Jin, Hongmei, et al.
Publicado: (2022)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Retracted: Comparative Analysis of Clinical Effects of Insulin Aspart Combined with Acarbose and Metformin in the Treatment of Diabetes Mellitus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
por: Detournay, Bruno, et al.
Publicado: (2020)

Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
por: Raccah, D., et al.
Publicado: (2017)

Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study
por: Li, Feng-fei, et al.
Publicado: (2015)

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes
por: Kim, Ji-Hyun, et al.
Publicado: (2015)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
por: Shafie, Asrul Akmal, et al.
Publicado: (2020)

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
por: Uzui, Hiroyasu, et al.
Publicado: (2011)

Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017)

Insulin for type 2 diabetes: choosing a second-line insulin regimen
por: Barnett, A, et al.
Publicado: (2008)

Comparison of Fetomaternal Outcomes in Patients With Gestational Diabetes Mellitus Treated With Insulin Versus Acarbose: Results of a Prospective, Open Label, Controlled Study
por: Jayasingh, Suryakanta, et al.
Publicado: (2020)

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
por: Yavuz, Dilek Gogas, et al.
Publicado: (2015)

Inpatient management of type 2 Diabetes Mellitus: Does choice of insulin regimen really matter?
por: Akhtar, Syed Tehseen, et al.
Publicado: (2014)

Selecting Insulin Regimens for the Management of Non-ICU Patients With Type 2 Diabetes
por: Migdal, Alexandra L, et al.
Publicado: (2021)

Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China
por: Zhang, Rong, et al.
Publicado: (2022)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes
por: Asias, Bernadette D., et al.
Publicado: (2015)

Gestational diabetes mellitus: Non-insulin management
por: Magon, Navneet, et al.
Publicado: (2011)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus()
por: Wang, Hua, et al.
Publicado: (2013)

Comparison of Glucose Lowering Effect of Metformin and Acarbose in Type 2 Diabetes Mellitus: A Meta-Analysis
por: Gu, Shuyan, et al.
Publicado: (2015)

Meta-analysis of insulin aspart versus regular human insulin used in a basal–bolus regimen for the treatment of diabetes mellitus
por: Heller, Simon, et al.
Publicado: (2013)

Multiple daily injection of insulin regimen for a 10-month-old infant with type 1 diabetes mellitus and diabetic ketoacidosis
por: Park, Ji Hyun, et al.
Publicado: (2016)

Effect of switching basal insulin regimen to degludec on quality of life in Japanese patients with type 1 and type 2 diabetes mellitus
por: Okada, Morihiro, et al.
Publicado: (2015)

Low Dose Insulin Regimen for Diabetic Coma
por: Asplin, C. M.
Publicado: (1976)

Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients
por: Kim, Jong-Dai, et al.
Publicado: (2016)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2
por: Marušić, Marinko, et al.
Publicado: (2021)

An introduction to insulin use in type 2 diabetes mellitus
por: Coetzee, Ankia
Publicado: (2023)

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes
por: Wu, Ted, et al.
Publicado: (2015)

The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2021)

Complications in neonates of mothers with gestational diabetes mellitus receiving insulin therapy versus dietary regimen
por: Fazel-Sarjoui, Zhaleh, et al.
Publicado: (2016)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus
por: Li, Willis, et al.
Publicado: (2021)

Inpatient use of metformin and acarbose is associated with reduced mortality of COVID‐19 patients with type 2 diabetes mellitus
por: Li, Jinghong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hn5ouosj7spnb4c1otfb1r3pip